Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Bryan Brown

Hand Surgery Orlando, FL Medical Doctor

NPI 1003296328 CMS profile 1367585

1222 S Orange Ave, 5Th Floor, Orlando, FL 32806

Open in the dashboard

General payments

$27,387

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bryan Brown of Orlando, FL is reported in the CMS Open Payments database as having received $27,387 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,437 17
2024 General $4,276 27
2023 General $6,220 30
2022 General $6,077 23
2021 General $4,683 18
2020 General $681 4
2019 General $2,012 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bryan Brown
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Bryan Brown were reported at $3,437. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Bryan Brown Hand Surgery median Middle half National median
2019 $2,012 $383 $106–$1,905 $163
2020 $681 $172 $51–$1,268 $114
2021 $4,683 $263 $71–$1,591 $132
2022 $6,077 $336 $87–$1,938 $149
2023 $6,220 $233 $81–$1,114 $160
2024 $4,276 $258 $88–$1,203 $164
2025 $3,437 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $12,161 22 payments
  2. Fones Marketing Management, Inc. $5,790 18 payments
  3. ImpactOrtho, Inc. $2,400 2 payments
  4. Stryker Corporation $1,547 25 payments
  5. Integra LifeSciences Corporation $1,046 15 payments
  6. Smith+Nephew, Inc. $747 13 payments
  7. Encore Medical, LP $699 5 payments
  8. Medical Device Business Services, Inc. $620 2 payments
  9. FX Shoulder USA, Inc $521 2 payments
  10. TriMed, Inc. $351 3 payments
  11. Other $1,504 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $9,537 10 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,500 4 payments
  3. Food and Beverage $6,369 114 payments
  4. Travel and Lodging $1,981 10 payments
Products named General payments · program years 2019–2025
  1. DJO Surgical AltiVate Reverse $699 5 payments
  2. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $614 9 payments
  3. PRIMATRIX $442 5 payments
  4. INTEGRA DERMAL REGENERATION TEMPLATE $442 5 payments
  5. NA $363 3 payments
  6. TENOGLIDE $319 5 payments
  7. Integra Recon-Skin And Wound $317 4 payments
  8. Integra Recon-Skin And Wound $317 4 payments
  9. Integra Recon-Skin And Wound $317 4 payments
  10. DJO Surgical Discovery Elbow System $300 2 payments
  11. Other $4,621 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

223

Median for Orthopedic Surgery: 203

Drug cost

$744

Median for Orthopedic Surgery: $1,433

Branded share of claims

31.4%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 153 $468
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $144
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 29 $132

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 106 billing codes

Paid by Medicare

$223,884

Of which drugs: $1,629

Medicare patients

425

Average age 73

Services billed

1,999

269 women, 156 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Ischemic heart disease 40%
Diabetes 31%
Depression 27%
Chronic kidney disease 24%
Osteoporosis 20%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 119 291 $1,583

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record